BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1925493)

  • 1. Model mice. Transgenic animals and Alzheimer's research.
    Erickson D
    Sci Am; 1991 Sep; 265(3):34. PubMed ID: 1925493
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling Alzheimer's disease in transgenic mice.
    Duff K
    J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease as copper deficiency.
    Klevay LM
    Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
    Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steps towards a mouse model of Alzheimer's disease.
    Crowther RA
    Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
    Santiard-Baron D; Aupetit J; Janel N
    Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mouse and chemical lesion approaches to the study of Alzheimer's disease.
    Tang F; Li H; Nag S; Xu G; Chan T
    Chin Med J (Engl); 1997 Aug; 110(8):642-7. PubMed ID: 9594272
    [No Abstract]   [Full Text] [Related]  

  • 10. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models.
    Brendza RP; Bales KR; Paul SM; Holtzman DM
    Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304
    [No Abstract]   [Full Text] [Related]  

  • 14. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?
    Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL
    Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
    Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
    Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's assault.
    Science; 1992 Feb; 255(5048):1059. PubMed ID: 1546303
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.
    Giovannini MG; Cerbai F; Bellucci A; Melani C; Grossi C; Bartolozzi C; Nosi D; Casamenti F
    Neuroscience; 2008 May; 153(3):618-33. PubMed ID: 18406062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice.
    Arendash GW; Cox AA; Mori T; Cracchiolo JR; Hensley KL; Roberts LJ
    Neuroreport; 2009 Aug; 20(12):1087-92. PubMed ID: 19543132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
    Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning and memory in transgenic mice modeling Alzheimer's disease.
    Ashe KH
    Learn Mem; 2001; 8(6):301-8. PubMed ID: 11773429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.